About this trial
The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Any surgery involving a non-urogynecologist
Patients already on an alpha blocker
Baseline hypotension
History of syncope
Trial design
Parallel
Treatments tested in this trial
Tamsulosin
DrugThis intervention will investigate if tamsulosin will decrease postoperative urinary retention. Subjects will be directed to start taking the medication 5-7 days prior to their procedure; as previous studies have shown, this is when tamsulosin reaches its steady state. Patients will continue to take their assigned pills for 7 days postoperatively.
Placebo
DrugThis intervention will ensure blinding and an accurate measure of the real effect of tamsulosin.
Treatment groups
Trial outcomes
Primary outcomes
Voiding trial on postoperative day 0
Whether or not patients pass or fail their postoperative voiding trial
Secondary outcomes
Secondary postoperative urinary retention
Patients who develop urinary retention after discharge
Postoperative urinary tract infection
Patients who develop a urinary tract infection after surgery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.